SeaStar Medical Holding Corporation

SeaStar Medical Holding Corporation

$8.6
0.94 (12.27%)
NASDAQ
USD, US
Biotechnology

52 Week Range

3.25-42.925

Beta

-1.05

Market Cap

$27.7M

Last Dividend

0

PE (TTM)

-17.14

Dividend Yield (TTM)

0

Price Chart

Industry

Biotechnology

Sector

Healthcare

CEO

Mr. Eric Schlorff

Full-Time Employees

12

IPO Date

2021-03-18

Description

SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.

Phone

844 427 8100

Address

3513 Brighton Boulevard, Denver, CO, 80216, US

CIK

0001831868